Aldeyra Therapeutics Reports First-Quarter 2022 Financial Results and Recent Corporate Highlights

Go back to Aldeyra Therapeutics Reports First-Quarter 2022 Financial Results and Recent Corporate Highlights

Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 3c

May 5, 2022 7:29 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More